Collection of Blood, Bone Marrow and Tissue Samples for the Investigation of the Human Immune Response, Lymphoma Biology and HTLV-1 Infection

Date de début de l'étude : 7 juin 1997

INCLUSION CRITERIA: Participants must meet at least one of these criteria: Have suspected or known disorder of the immune system or cancer Be a known or potential carrier of autoimmune disorder or immunodeficiency disease. Specific disorders may include but are not limited to: X-linked (severe combined immunodeficiency) Autosomal recessive SCID X-linked CD40 ligand deficiency Common variable immunodeficiency Ataxia-telangiectasia Wiskott Aldrich syndrome DiGeorge syndrome Infection with HTLV-1 Age greater than or equal to 18 years. Participant must be able to understand and sign informed consent. Participants who will undergo apheresis must have hematocrit greater than 28%, and platelet count greater than 50,000. Subjects for whom apheresis is desired but whose counts are lower than those above must be evaluated and approved by a Department of Transfusion Medicine consult physician. Weight greater than 25 kg is necessary for apheresis. EXCLUSION CRITERIA: Overall Exclusion Criteria: Pregnant women will not be eligible for any aspect of this protocol. Exclusion Criteria for Apheresis Alone: Any diagnosed medical condition which may be worsened by the apheresis procedure. Specifically the participant should not have any of the following: Congestive Heart Failure History of angina Severe hypotension (at the discretion of the participant's physician, the apheresis staff and the attending physician from the Department of Transfusion Medicine (DTM) per DTM Standard Operating Policies.) Poorly controlled hypertension (average baseline blood pressure greater than 160/90) History of a coagulation protein disorder. Pediatric patients (less than 18 years) will not undergo apheresis.